Search Thermo Fisher Scientific
| 8:00 a.m. | Sign up and Networking | |
| 8:30 a.m. | Welcome and VIP Introduction | |
| 8:30 a.m. | Opening Remarks | |
| Dr. Martin J. Murphy | Summit Co-Chair, Chief Executive Officer, CEO Roundtable on Cancer | |
| Dr. WANG Chen | Summit Co-Chair, President, China Academy of Medical Sciences and Peking Union Medical College | |
| Terry Branstad | United States Ambassador to China | |
| 8:45 a.m. | Sponsor Remarks | |
| Mark Stevenson | Executive Vice President and Chief Operating Officer, Thermo Fisher Scientific | |
| Session One: Ending Cancer needs China - U.S. Collaboration on Precision Medicine | ||
| 8:50 a.m. | Keynote speech: Preventing Cervical Cancer in China, the United States and Globally | |
| Dr. Douglas Lowy Deputy Director National Cancer Institute | ||
| 9:15 a.m. | Keynote speech: Research and Development of a Precise Anti-Cancer Drug - Our Experience and Strategy | |
| Prof. LI Jin President of Chinese Society for Clinical Oncology, Director, Medical Oncology, East Hospital Tongji University | ||
| 9:40 a.m. | Panel discussion International Framework on Precision Medicine with Outstanding Contribution from China and U.S. | |
| Moderator | ||
| Dr. Martin J. Murphy | Chief Executive Officer; CEO Roundtable on Cancer | |
| Panelists | ||
| Dr. WANG Chen | President China Academy of Medical Sciences and Peking Union Medical College | |
| Dr. Douglas Lowy | Deputy Director National Cancer Institute | |
| Prof. LI Jin | President of Chinese Society for Clinical Oncology Director, Medical Oncology, East Hospital Tongji University | |
| Dr. WANG Yu | Former Director General Chinese Center for Disease Control and Prevention | |
| 10:10 a.m. | Coffee Break | |
| Session Two: Accelerating Precision Medicine – Roles and Responsibilities of Industry, Academia and the Clinic | ||
| 10:40 a.m. | Keynote speech: The Future of Precision Medicine on Cancer Research in China | |
| Prof. ZHAN Qimin President, Peking University Health Science Center (PKUHSC) Vice President, Peking University | ||
| 11:05 a.m. | Keynote speech: Value of a Dynamic Precision Medicine Eco System for a Healthier China | |
| Tony Acciarito President, Thermo Fisher Scientific China | ||
| 11:30 a.m. | Keynote speech: Transform the Oncology Research to Real Clinical Benefit for Patients – Experience from Industry | |
| Dr. Steffan Ho Vice President and Head of the Translational Oncology Group Pfizer | ||
| 11:55 a.m. | Panel discussion Looking Towards a World Without Cancer | |
| Moderator | ||
| Dr. Corina Shtir | Head of Precision Medicine, Thermo Fisher Scientific | |
| Panelists | ||
| Dr. Joseph Eid | Global Head of Medical Affairs, Bristol Myers Squibb (BMS) | |
| Dr. Matthew D. Brown | Director, China Office, Center for Global Health, National Cancer Institute, National Institutes of Health | |
| Prof. LIU Yuanli | Dean, School of Public Health, China Academy of Medical Sciences and Peking Union Medical College | |
| Prof. Dong Zigang | Executive Director, The Hormel Institute, University of Minnesota, McKnight Presidential Professor of Cancer Prevention, Hormel/Knowlton Professor, I. J. Holton Professor | |
| 12:25 p.m. | Luncheon | |
| 1:45 p.m. | Keynote speech: Single Cell Genomics: MALBAC in Reproductive Health and Inherited Disease | |
| Prof. QIAO Jie President, Peking University Third Hospital Academician of China Academy of Engineering | ||
| 2:05 p.m. | Keynote speech: Metagenomics - Reproductive Health and Inherited Disease | |
| Prof. LIAO Can President, Guangzhou Women and Children’s Medical Center | ||
| 2:25 p.m. | Keynote speech: Oncology: Biomarker Selection in Cancer Diagnosis and Therapy | |
| Prof. QIN Jun Director, National Center for Protein Science Beijing | ||
| 2:45 p.m. | Panel Discussion: Technical Advances Shaping Precision Medicine | |
| Moderator | ||
| Prof. Bruce Ling | Director Translational Medicine Stanford University | |
| Panelists | ||
| Dr. Todd Hembrough | President, Proteomics, NantOmics, LLC | |
| William Liang | Vice President, Head of China Oncology AstraZeneca | |
| Prof. Andrew Kasarskis | Director, Icahn Institute for Genomics and Multiscale Biology | |
| Prof. Catherine Wong | Director of Precision Medicine Multi-Omics Center, Peking University Health Science Center | |
| Dr. CAI Long | President, National Health and Medicine Big Data (Nanjing) Center | |
| Prof. Nam Do Hyun | Director Samsung Institute of Refractory Cancer | |
| 3:25 p.m. | Coffee Break | |
| 3:55 p.m. | Keynote speech: Precise Diagnosis and Treatment of Pediatric Cancer: Real World Experience at Children’s Hospital Los Angeles | |
| Prof. Timothy Triche Professor, Pathology and Pediatrics, Keck School of Medicine at USC and Co-Director, Center for Personalized Medicine, Childrens, Hospital Los Angeles (CHLA) | ||
| 4:15 p.m. | Keynote speech: Promise of CAR T-Cell Therapy for the Treatment of Cancer | |
| Prof. ZHAO Yangbing Director, T Cell Engineering Laboratory, Department of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine | ||
| 4:35 p.m. | Keynote speech: Precise Prevention of Cervical Cancer and HPV Vaccination in China | |
| Prof. QIAO Youlin Director for Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College | ||
| 4:55 p.m. | Panel discussion: Impact of Digital Health for Precision Medicine | |
| Moderator | ||
| Dr. Alan Sachs | Chief Scientific Officer, Thermo Fisher Scientific | |
| Panelists | ||
| Prof. LI Yixue | Director, Shanghai Center for Bioinformation Technology | |
| Dr. YANG Hongwei | Former Deputy Director China National Health Development Research Center | |
| Dr. Frank Su | Founding Partner of Redhill Capital | |
| Dr. Seth Sadis | Director, Oncology Informatics and Software, Clinical Sequencing Division Thermo Fisher Scientific | |
| 5:35 p.m. | Closing Remark by Chairman and Event Ends | |